BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:RP902 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of RP902\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07579884-776@assetmemo.bio
DTSTAMP:20261121T005822Z
DTSTART;VALUE=DATE:20290531
DTEND;VALUE=DATE:20290601
SUMMARY:RP902: Phase 2 readout est. (NCT07579884)
DESCRIPTION:RP902\, phase 2.\nStudy: To Evaluate the Safety and Efficacy of
  RP902 Tablets\nEstimated primary completion: May 2029. This is a Clinical
 Trials.gov estimate\, not a confirmed readout date\, and it can move.\nDru
 g page: https://assetmemo.bio/drug/rp902#upcoming-events\nRegistry record:
  https://clinicaltrials.gov/study/NCT07579884
URL:https://assetmemo.bio/drug/rp902#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
